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The 26S proteasome is thought to be a homogenous complex, consisting of a 20S proteolytic core
and a 19S regulatory particle that is required for its activation.
Two groups have recently reported the activation of archeal 20S by a p97-related double-ring AAA+
ATPase complex, in a similar fashion to that reported for 19S. Since p97 is found in eukaryotes, the exis-
tence of a parallel setting in higher organisms is intriguing. Herein, we present supporting data and
hypothesize that in eukaryotes, p97 and CSN form a promiscuous, hence hard-to-detect, ‘‘alternative
cap’’, enabling the prompt and precise elimination of particular substrates.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Rapid response of cells to environmental changes or stress is
key for all domains of life. Adjustment to new circumstances re-
quires alterations of the cellular environment through degradation
of unneeded proteins by the 26S proteasome, a master regulator of
cellular quality control [1]. The 26S proteasome is a mega complex,
arranged in 2 major assemblages: the 20S core particle (CP), a bar-
rel-shaped complex, which is composed of 4 stacked heptameric
rings (a,b,b,a), forming a tightly sealed gated cylinder, and the
19S regulatory particle (RP), which caps the 20S CP and controls/
activates the entrance into the proteolytic cavity. The 19S RP (also
referred to as ‘‘cap’’) is divided into lid and base assemblies. The lid
is composed of 9 subunits (Rpn3, 5–9, 11, 12, and 15) and has a
deubiquitinase enzymatic activity essential for proteolysis (do-
nated by Rpn11). The base includes 2 large solenoid-shaped sub-
units (Rpn1, 2), 2 ubiquitin receptors (Rpn10, 13), and a motor
AAA+ ATPase ring, which comprises 6 distinct subunits (Rpt1–6),
and is required for the unfolding of substrates, opening the gate,and translocating substrates into the 20S CP [2]. Recent cryo-elec-
tron microscopy studies have provided evidence that several lid
subunits interact directly with the AAA+ motor domain within sev-
eral Rpt subunits (Rpn7 with Rpt2/6; rpn5/6 with Rpt3) [3–7] and
even with the 20S (i.e. Rpn6) [8], suggesting that the Rpt1–6 ATP-
ases ring is more static than was thought and might be motivated
through substantial conformational rearrangements achieved by
incorporation of the lid into the 26S holocomplex [5]. Activation
of the 20S by the 19S involves interactions with a binding pocket
within the a ring of the 20S CP, causing extensive conformational
changes in the 20S and resulting in gate opening [9].
The ubiquitin proteasome system (UPS) plays an essential role
in a variety of fundamental cellular processes. Not surprisingly,
multiple proteasome activators (PA) exist in addition to the well-
studied default 19S RP conﬁguration. Three proteasome regulators,
PA28/11S, PA200/Blm10, and ECM29, were found to compete with
the 19S RP on the a-ring activation-binding site, in a non-ATP-
dependent manner [10]. The PA28/11S consists of heterohepta-
meric (a,b,c) rings, is induced by interferon-c, associated with
the 20S, and involved in immune response [11]. PA200/Blm10 acti-
vates the 20S and has a role in spermatogenesis, DNA repair, and
other pathways [12]. ECM29, functions as a chaperon and stabilizer
of proteasome 20S–19S interactions, as well as a negative regula-
tor, which suppresses gate opening and causes proteasome block-
age [13–16]. However, because interaction with the 20S CP (upon a
speciﬁc cellular function or stress) could be transient, the list of
proteasome regulators in eukaryotes might be longer and difﬁcult
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one homogenous entity, and the exact number of PA-complexes
and their respective roles is thus far, shrouded in mystery (Fig. 1).
Whereas both 19S substructures (base and lid) are found only in
eukaryotes, a base-like subcomplex composed of AAA+ ATPases is
found in several prokaryotes, with a conserved evolutionary role
in acceleration of selective proteolysis. A few examples are ARC
(Rhodococcus erythropolis), or MPA (Mycobacterium tuberculosis)
that activate bacterial orthologs of the 20S proteasome [10,17].
Other bacterial examples are ClpA, C, or X, all of which activate
the ClpP protease [18]. In archea, a homohexameric ring that is lo-
cated proximally to the catalytic 20S subcomplex is known as PAN
(proteasome-activating nucleotidase) [19]. PAN exhibits the high-
est homology with the eukaryotic Rpt-ring of ATPases, and shares
more than 40% of amino acid similarity with them [20]. Interest-
ingly, PAN is absent in several archea and is not required for viabil-
ity of other archea in which the 20S exists and is required for
protein degradation.
2. New insights regarding proteasome activators based on
studies in archea
Recent studies have suggested a regulatory network of protea-
some AAA+ ATPases across the archea kingdom. Bioinformatics
analysis suggests that PAN is not alone, and that the putative num-
ber of proteasome ATPases in archea varies between 1 and 5,Fig. 1. Understanding proteasome function and regulation. Similar to the story
about the blindfolded scientists who described an elephant differently according to
the organ they held, the role and control systems of the proteasome are not fully
understood in the scientiﬁc world.including the double ring AAA+ ATPase Cdc48/p97/VAT (p97),
which is conserved from archea to humans. Interactions between
archeal p97 and 20S CP, and formation of active proteasomes were
found so far in 2 organisms, Thermoplasma acidophilum and Met-
hanosarcina Mazei [21–23]. These newly described assemblages
are actively involved in translocation of substrates into the prote-
olytic cavity [21,22]. Using bioinformatics tools, Barthelme and
Sauer [16] showed that p97 is the only 20S CP potential partner
in 15% of archea, and that both p97 and PAN exist in similar rates
in the remaining 85% of analyzed genomes [16]. Interactions be-
tween the 20S and p97 involve a similar, conserved C-terminal
hydrophobic-tyrosine-X motif (Hb-Y-X), which is also found in
PAN and the Rpt1–6 ring [24,25]. In all of these interactions, the
core complex is activated through docking of the activator into
the a-ring-binding pockets within the 20S (Fig. 2) [21,24–26].
Interestingly, the Hb-Y-X motif exists not only in other archeal
but also in eukaryotic p97 enzymes, suggesting a common mecha-
nism for activation of proteolysis and that p97 has the potential of
forming active proteasomes [16]. These new data raise questions
regarding the evolutionary conservation of this unconventional
architectural design (Fig. 2).3. p97 as a Proteasome activator: supporting information
Could it be that the eukaryotic p97 replaces the 19S and directly
promotes selective protein degradation? In eukaryotes, p97 ATPase
functions in a plethora of pathways with an important role in pre-
paring proteins for degradation through the 2 key degradation
apparatuses: the proteasome and the lysosome [27]. It participates
in a wide range of cellular processes including cell-cycle regula-
tion, response to DNA damage, ER degradation, and autophagy
[28]. Together with its counterparts, p97 binds to polyubiquitinat-
ed substrates and uses ATP to unwind them. If required, p97 also
functions to extract clients out of membranes or chromatin, and
to eventually facilitate their degradation [29].
The eukaryotic p97 interacts with substrates that are covalently
attached to a poly-ubiquitin chain through an array of p97-binding
factors, such as the Ufd1/Npl4 counterparts that are required for
extraction of substrates from chromatin and membranes, or mem-
bers of the UbX family that harbor a ubiquitin-binding domain
(UbD) and connect between p97 and substrates. Additionally,
p97 also binds to an array of deubiquitinating enzymes (DUbs)
such as the ovarian tumor protein Otu1, atx3 that regulates the
degradation of misfolded ER proteins, Yod that is included in ER
disclosure, or the Ubp3/Bre5 factors in budding yeast that are in-
volved in ribosome autophagy (ribophagy) [30–33]. Interactions
between 2 enzymes such as a DUb and an unfoldase (p97), could
be explained by the need for recycling of client proteins. Yet, in
addition to interactions with DUbs, the mammalian p97 interacts
also with the proteasome [34], and may have the potential to play
a role of PA, and to enable a prompt degradation of ubiquitinated
proteins in situ. p97 and the 19S-RP have common characteristics:
both include a molecular ATPase engine, interact with ubiquitin
shuttles and with deubiquitinating enzymes, and both are involved
in the regulation of proteolysis. Proteasome activation by p97
might explain the involvement of this molecule in the precise
and rapid degradation of a wide array of proteasome substrates.
Nevertheless, suggesting that eukaryotic p97 serves as an ‘‘alterna-
tive base’’ that activates the 20S-CP is unimaginable, because inter-
actions between p97 and the eukaryotic proteasome have so far
been conﬁrmed only through the 19S and not directly with the
20S [29,34].
Finley and Matouschek have suggested 2 models that may ex-
plain the contribution of p97 to the eukaryotic proteasome [23].
The ﬁrst model suggests that p97 was initially an integral part of
Fig. 2. A model for the formation of transient alternative proteasome activators required for the acceleration of ubiquitination/degradation of CRLs substrates. The 19S is a
canonical proteasome activator. Ubiquitinated substrates are being shuttled by a ubiquitin receptor to the 19S proteasome for deubiquitination (Lid) and unfolding (Base),
followed by activation of the 20S CP and proteolysis. The 19S is not always attached to the 20S, and 3 additional factors (PA28/11S, PA200/BLM10, and ECM29) regulate the
20S-CP conditionally, through interactions with similar residues, as does the 19S. The above mentioned model suggests an ‘‘alternative cap’’ assemblage, consisting of the CSN
and p97 complexes, that regulate not only the ubiquitination of particular substrates, but also ubiquitin hydrolysis (Lid-like activity), and unfolding (Base-like activity). As a
next step, alternative cap may cause to the activation of the 20S CP through interactions between the Hb-Y-X domain of p97 and speciﬁc residues within the alpha ring.
Alternative PA may gather only transiently, on one end of the proteasome, and may be dependent on a speciﬁc substrate, a CRL, or a shuttling factor (such as UbXD7). Blue
arrows show interactions conﬁrmed in the literature; Red dashed arrows show predicted interactions.
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the 20S-binding site, and interactions between p97 and the 20S
were lost, while the rest of the ubiquitin–proteasome related func-
tions of p97 were retained. The second model suggests that in
eukaryotes, p97 still plays a role as a base-like complex, but for a
subset of proteasome substrates that have not been identiﬁed thus
far. In our hypothesis, we favor an integrated model, by which p97
has lost conventional interactions with the 20S, yet, it preserves
promiscuous transient relationship with the 20S proteasome. The
interactions with the 20S proteasome require additional counter-
parts that together enable to conditionally mimic the 26S.
4. p97 couples ubiquitination and degradation of a precise set of
substrates
In archea, the variety of the proteasome components (including
redundancy of ATPases) is critical for survival under stresses [22].
However, in eukaryotes, the highest level of diversity in the ubiq-
uitin–proteasome pathway takes place mainly at the levels of ubiq-
uitin E3 ligases, which confer speciﬁcity to substrates through a
highly regulated mechanism [35,36]. Recently, several studies have
shown that p97 is involved in the regulation of ubiquitination
through direct interactions with ubiquitin E3 ligases, including
several members of the cullin-RING E3 ligase (CRLs) family [37–
42]. CRLs are the largest class of E3 ligases. Seven different cullin
scaffold proteins exist in humans, each of them serve as a buildingblock for the assembly of tens or more multi-subunit CRLs. Cullins
interact with a RING domain protein Rbx1/Rbx2, via its C-terminus
and to a cullin-speciﬁc substrate adaptor protein via its N-terminus
(with one exception of Cul3) [35,36]. Adaptors bind substrate-
receptors, which in turn recruit substrates for ubiquitination. CRLs
activity is highly regulated, and complexes are active when cova-
lently attached to the ubiquitin-related protein, Nedd8. Neddyla-
tion/deneddylation cycles are required for the proper regulation
of CRL function. A key regulator of CRLs activity is the COP9 sig-
nalosome (CSN), an 8-subunit complex that shows 1:1 paralogy
with each of the proteasome lid subunits [43]. Paralogy between
the CSN and the lid is also reﬂected by the enzymatic function:
while Rpn11 deconjugates ubiquitin from proteasome substrates,
its paralog in the CSN, Csn5 hydrolyses Nedd8/Rub1, the closest
paralog of ubiquitin from cullins [44]. The knowledge about regu-
lation of CRLs by the CSN has recently been expanded, when a few
independent groups found that the CSN controls CRLs activity also
in a non-enzymatic fashion [45–47].
Similar to the CSN, p97 also regulates CRLs activity, through its
counterpart UbXD7, a member of the UbX family. UbXD7 interacts
with the neddylated form of CRL2 and CRL4 and mediates their
interactions with p97 through its conserved ubiquitin-interacting
motif (UIM). It also interacts with polyubiquitin chains through
its UbX domain, and may act as a ubiquitin receptor through this
domain, and inhibit deneddylation through direct interactions
with Nedd8 (Fig. 2) [37–39].
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hypoxia-inducible factor Hif-a, substrate of CRL2Elo B-C/VHL, the
mitotic kinase Aurora B, and the yeast RNAPII catalytic subunit
(Rpb1), which are ubiquitinated by CRL3Klhl21 and CRL3Elc1/
Ela1, respectively, as well as the replication licensing factor Cdt1
which is targeted by CRL4ADdb1/Cdt2 [37–39,42]. However, deg-
radation of Cdt1 does not require interactions with UbxD7, and
might involve a yet undeﬁned UbX receptor ([48], Fig. 2).
5. Performing alternative caps to the proteasome: old model
with new insights
Similar to p97 and the ‘‘alternative-base’’ model [23], a model
for the CSN complex as an ‘‘alternative lid,’’ which modulates the
activity and efﬁciency of substrate ubiquitination and degradation
in a single conglomerate, has been previously suggested and re-
mains to be elucidated [49]. The 2 complexes, CSN and p97 share
few characteristics: both regulate the UPS, both interact with the
proteasome directly [20,34,50,51], both regulate CRLs (CSN inhibits
CRLs activity in vitro, and is, unexpectedly a positive regulator
in vivo [51]; p97 regulates CRLs through UbXD7 and may also have
positive and negative regulatory roles depending on substrates or
the performed study [36]), and both CSN and p97 are involved in
pleiotropic biological functions.
A previous study has shown that mammalian p97 interacts with
the CSN complex in an ATP-dependent manner, and may form an
ATP-dependent complex that resembles the 19S regulatory particle
[52]. Both deubiquitinase and deneddylase activities of the CSN are
required for the binding between p97 and polyubiquitinated sub-
strates [52]. In addition, studies conducted in human B8 ﬁbroblasts
cells have shown that CSN interacts directly with the proteasome
and competes with the lid, thereby impacting the peptidase activ-
ity of the proteasome in vitro [48]. Considering all of the above-
mentioned data, it is intriguing to predict that p97 activates
proteasomes through transient interactions between its HY-b-X
motif and the 20S on one side [21,22], and on the other side accom-
plishes roles such as unfoldase and deubiquitinase through inter-
actions with the CSN (Fig. 2) [52]. It will be interesting to go one
step further and revive the old ‘‘alternative lid’’ model; however,
the new model requires substitution of the base, and might impri-
son a CRL complex, together with shuttling molecules such as a
UbX protein in-between (Fig. 2), while the ‘‘other side’’ of the pro-
teasome may still bind conventional 19S-RP. Such a conditional
assemblage would be very hard to detect using conventional struc-
tural methodologies. Obviously, this predicted proteasome sub-
complex is not commonly found. Perhaps, it performs
promiscuous interactions with the 20S, and requires regulation of
a speciﬁc substrate, ligase, or shuttling factor. Nevertheless, such
a mechanism may enable the precise and prompt elimination of
substrates.
6. Concluding remarks
The 2 protein complexes, CSN and p97 possess structural and
functional paralogy with the 19S RP lid and base subcomplexes,
respectively. p97 and the Rpt1–6 ring of ATPases function as unfol-
dase, while the CSN and the lid function in hydrolysis of members
of the ubiquitin family. Just as in the aforementioned models, we
also suggest that the eukaryotic p97 (as well as the CSN complex)
have evolved a new function and lost the ability to function as a
proteasome regulatory particle. Nevertheless, we hypothesize that
p97 is still able to play a promiscuous role, and moonlight within
the proteasome under certain conditions, a phenomenon that
might represent an intermediate phase for the evolvement of this
complex. Such as other moonlighting proteins, this interaction istransient, and is difﬁcult to detect. Moonlighting of paralog com-
plexes in the proteasome, playing as ‘‘conventional homologs’’
could elucidate a sophisticated mechanism to elevate the complex-
ity within the ubiquitin proteasome system and provide an addi-
tional level of speciﬁcity by building distinct types of
proteasomes from existing regulators, without requiring extension
of the genome.
We assume that proteasome activation by a complex such as
the p97/CSN could be unstable under standard laboratory condi-
tions. Future analysis should therefore be performed in response
to diverse stimuli, or environments (such as stressors), followed
by analysis of conditional protein–protein interactions that may
bring ubiquitination in close proximity with the proteasome, mod-
ulating efﬁcient turnover of selected CRL complexes and their
substrates.
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